ArriVent BioPharma Inc - fluxo de caixa trimestral (NASDAQ:AVBP) | MetaTrader

Abrir gráfico completo

Financials

Visão geral Relatórios Estatísticas

Total assets 274.94 M215.5 M269.51 M326.56 M333.17 M Total liabilities 17.29 M12.95 M19.64 M21.56 M25.95 M Total equity 257.65 M202.54 M249.87 M305 M307.22 M Total liabilities & shareholders' equities 274.94 M215.5 M269.51 M326.56 M333.17 M Total debt ————— Net debt —————

Notícias

Are You Looking for a Top Momentum Pick? Why ArriVent BioPharma, Inc. (AVBP) is a Great Choice

Are Medical Stocks Lagging AstraZeneca (AZN) This Year?

Ações da Arrivent Biopharma atingem máxima de 52 semanas a US$ 27,25

Are Medical Stocks Lagging ArriVent BioPharma, Inc. (AVBP) This Year?

ArriVent BioPharma: Phase 3 Delay May Signal Stronger Outcomes For Firmonertinib (NASDAQ:AVBP)

BTIG inicia cobertura de ações da ArriVent com recomendação de compra pelo pipeline oncológico

BTIG initiates ArriVent stock coverage with buy rating on oncology pipeline

Wall Street Analysts See a 70.37% Upside in ArriVent BioPharma, Inc. (AVBP): Can the Stock Really Move This High?

Is ArriVent BioPharma, Inc. (AVBP) Stock Outpacing Its Medical Peers This Year?

Cantor Fitzgerald reitera classificação acima da média para ações da ArriVent

ArriVent stock rating reiterated as Overweight by Cantor Fitzgerald

Oppenheimer reitera classificação acima da média para ações da ArriVent BioPharma